The human ESR2 gene (estrogen receptor β) promoter contains a known SNP marker (rs35036378) of a primary ESR2-deficient pT1 tumor whose development can lead to breast cancer without proper preventive treatment [116] (Table 3). Here, ESR2 is linked to neoplasm.